GlaxoSmithKline sets sights on carbon neutrality
Drug company GlaxoSmithKilne has committed to becoming carbon neutral by 2050. It has already cut emissions by 4% over the past three years, but questions remain over how it will achieve its goal.

Drug company GlaxoSmithKilne has committed to becoming carbon neutral by 2050. It has already cut emissions by 4% over the past three years, but questions remain over how it will achieve its goal.